US5922340A
(en)
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
CN1074923C
(zh)
*
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
EP1649850A1
(en)
*
|
1993-11-19 |
2006-04-26 |
Alkermes Controlled Therapeutics Inc. II |
Preparation of biodegradable microparticles containing a biologically active agent
|
US5879712A
(en)
*
|
1995-06-07 |
1999-03-09 |
Sri International |
Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced
|
DE69632569T2
(de)
|
1995-06-09 |
2005-08-18 |
Euroceltique S.A. |
Formulierungen und verfahren für eine verlängerte lokalanästhesie
|
WO1997002019A1
(en)
*
|
1995-06-30 |
1997-01-23 |
Baylor University |
Polyester/carboxylic acid composite materials
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
EP0862419B2
(en)
|
1995-11-09 |
2010-11-17 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
DE19545257A1
(de)
*
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
GB2310801A
(en)
*
|
1996-03-04 |
1997-09-10 |
Merck & Co Inc |
Process for removing an organic solvent from lactide-glycoside copolymer microspheres
|
US5792477A
(en)
*
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
MY118174A
(en)
*
|
1996-05-07 |
2004-09-30 |
Alkermes Inc |
Process for the preparation of microparticles
|
TW487572B
(en)
*
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
AU733867B2
(en)
*
|
1996-06-24 |
2001-05-31 |
Euro-Celtique S.A. |
Methods for providing safe local anesthesia
|
JP2001500254A
(ja)
*
|
1996-08-23 |
2001-01-09 |
アボツト・ラボラトリーズ |
物質を粒子に付着させる手順
|
US6046187A
(en)
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5945126A
(en)
*
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
PT996426E
(pt)
|
1997-06-05 |
2007-06-18 |
Bertex Pharma Gmbh |
Sistema multifásico
|
CA2271750C
(en)
|
1997-07-02 |
2004-04-27 |
Euro-Celtique, S.A. |
Prolonged anesthesia in joints and body spaces
|
ES2248914T3
(es)
|
1997-08-29 |
2006-03-16 |
Corixa Corporation |
Agentes bioactivos encapsulados de liberacion rapida que permiten inducir o potenciar una respuesta inmunitaria y metodos para utilizar los mismos.
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
US6451335B1
(en)
|
1998-07-02 |
2002-09-17 |
Euro-Celtique S.A. |
Formulations and methods for providing prolonged local anesthesia
|
US6270802B1
(en)
|
1998-10-28 |
2001-08-07 |
Oakwood Laboratories L.L.C. |
Method and apparatus for formulating microspheres and microcapsules
|
US6194006B1
(en)
*
|
1998-12-30 |
2001-02-27 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of microparticles having a selected release profile
|
US6498153B1
(en)
*
|
1998-12-31 |
2002-12-24 |
Akzo Nobel N.V. |
Extended release growth promoting two component composition
|
US6204308B1
(en)
|
1999-03-01 |
2001-03-20 |
Novartis Ag |
Organic compounds
|
EP1044683A1
(en)
*
|
1999-04-15 |
2000-10-18 |
Debio Recherche Pharmaceutique S.A. |
One-step dispersion method for the microencapsulation of water soluble substances
|
US6291013B1
(en)
*
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
DE19925184A1
(de)
*
|
1999-05-26 |
2000-11-30 |
Schering Ag |
Kontinuierliches Verfahren zur Herstellung von morphologisch einheitlichen Mikro- und Nanopartikeln mittels Mikromischer sowie nach diesem Verfahren hergestellte Partikel
|
GB9914412D0
(en)
*
|
1999-06-22 |
1999-08-18 |
Worrall Eric E |
Method for the preservation of viruses,bacteria and biomolecules
|
FR2797784B1
(fr)
*
|
1999-08-27 |
2001-11-30 |
Mainelab |
Procede d'encapsulation de matieres actives par coacervation de polymeres en solvant organique non-chlore
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US6331317B1
(en)
|
1999-11-12 |
2001-12-18 |
Alkermes Controlled Therapeutics Ii Inc. |
Apparatus and method for preparing microparticles
|
US6705757B2
(en)
|
1999-11-12 |
2004-03-16 |
Alkermes Controlled Therapeutics, Inc. Ii |
Method and apparatus for preparing microparticles using in-line solvent extraction
|
US6495166B1
(en)
*
|
1999-11-12 |
2002-12-17 |
Alkermes Controlled Therapeutics Inc. |
Apparatus and method for preparing microparticles using in-line solvent extraction
|
PT1248596E
(pt)
|
2000-01-11 |
2007-06-21 |
Bertex Pharma Gmbh |
Kit para implantações contendo uma fase de veículo e um solvente
|
DK1255547T3
(da)
|
2000-02-08 |
2008-12-01 |
Euro Celtique Sa |
Kontrolleret-frigivelsessammensætninger indeholdende opioid-agonist og antagonist
|
GB0008411D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Vectura Ltd |
Pharmaceutical preparations and their manufacture
|
AR023940A1
(es)
|
2000-05-03 |
2002-09-04 |
Eriochem Sa |
Procedimiento para la produccion de microcapsulas de liberacion prolongada de peptidos solubles en agua
|
US6264987B1
(en)
*
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
IL153058A0
(en)
*
|
2000-05-24 |
2003-06-24 |
Jordan Loyal Holtzman |
Agents and methods for increasing brain chaperonin levels
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
US6467949B1
(en)
*
|
2000-08-02 |
2002-10-22 |
Chemineer, Inc. |
Static mixer element and method for mixing two fluids
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
KR100867392B1
(ko)
*
|
2000-08-15 |
2008-11-06 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
마이크로입자
|
DE10044545A1
(de)
*
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US6482440B2
(en)
|
2000-09-21 |
2002-11-19 |
Phase 2 Discovery, Inc. |
Long acting antidepressant microparticles
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
US7666445B2
(en)
*
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
ES2326209T3
(es)
|
2000-10-27 |
2009-10-05 |
Baxter Healthcare S.A. |
Produccion de microesferas.
|
US20020114843A1
(en)
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
WO2002058670A1
(en)
*
|
2001-01-25 |
2002-08-01 |
Euroceltique S.A. |
Local anesthetic, and method of use
|
CA2438208A1
(en)
*
|
2001-02-07 |
2002-08-15 |
Durect Corporation |
Devices and methods for management of bone density
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
ES2307779T3
(es)
*
|
2001-08-16 |
2008-12-01 |
Baxter International Inc. |
Formulaciones de microparticulas a base de propelentes.
|
US20080026068A1
(en)
*
|
2001-08-16 |
2008-01-31 |
Baxter Healthcare S.A. |
Pulmonary delivery of spherical insulin microparticles
|
EP1446100B1
(en)
*
|
2001-11-14 |
2011-05-04 |
Durect Corporation |
Injectable depot compositions and uses thereof
|
NZ533436A
(en)
*
|
2001-11-14 |
2007-10-26 |
Alza Corp |
Catheter injectable depot compositons and uses thereof
|
AU2003221497A1
(en)
*
|
2002-03-13 |
2003-09-22 |
Novartis Ag |
Pharmaceutical microparticles
|
PT2561860T
(pt)
*
|
2002-05-31 |
2018-05-08 |
Titan Pharmaceuticals Inc |
Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US7838034B2
(en)
*
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
KR20050038008A
(ko)
*
|
2002-07-31 |
2005-04-25 |
알자 코포레이션 |
주사용 저장형 조성물 및 이의 용도
|
EP1556018A1
(en)
*
|
2002-09-30 |
2005-07-27 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
US7544657B2
(en)
*
|
2002-10-02 |
2009-06-09 |
Zealand Pharma A/S |
Stabilized Exendin-4 compounds
|
US20040071848A1
(en)
*
|
2002-10-15 |
2004-04-15 |
Cargill Inc. |
Process for producing cocoa butter and cocoa powder by liquefied gas extraction
|
US20040071847A1
(en)
*
|
2002-10-15 |
2004-04-15 |
Cargill, Inc. |
Producing cocoa powders with different cocoa butter contents by liquefied gas extraction on substantially the same production line
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
AU2003295409B2
(en)
|
2002-11-06 |
2010-02-11 |
Durect Corporation |
Controlled release depot formulations
|
ES2359977T3
(es)
|
2003-03-31 |
2011-05-30 |
Titan Pharmaceuticals, Inc. |
Dispositivo polimérico implantable para liberación sostenida de agonista de dopamina.
|
JP2007515392A
(ja)
|
2003-04-10 |
2007-06-14 |
ピーアール ファーマシューティカルズ,インコーポレイテッド |
エマルジョンベースの微粒子の製造のための方法
|
US20070207211A1
(en)
*
|
2003-04-10 |
2007-09-06 |
Pr Pharmaceuticals, Inc. |
Emulsion-based microparticles and methods for the production thereof
|
CN100571682C
(zh)
|
2003-06-03 |
2009-12-23 |
参天制药株式会社 |
微粒的制造方法
|
WO2004108084A2
(en)
*
|
2003-06-04 |
2004-12-16 |
Alkermes Controlled Therapeutics, Ii |
Polymorphic forms of naltrexone
|
JP5165239B2
(ja)
*
|
2003-07-15 |
2013-03-21 |
ピーアール ファーマシューティカルズ, インコーポレイテッド |
制御放出処方物の調製のための方法
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
CN1826170B
(zh)
*
|
2003-07-18 |
2010-12-08 |
巴克斯特国际公司 |
通过受控相分离制备的小球形颗粒的制造方法、其用途和成分
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
JP2007508240A
(ja)
*
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
ES2741576T3
(es)
|
2003-07-23 |
2020-02-11 |
Evonik Corp |
Composiciones de liberación controlada
|
US6987111B2
(en)
|
2003-08-06 |
2006-01-17 |
Alkermes Controlled Therapeutics, Ii |
Aripiprazole, olanzapine and haloperidol pamoate salts
|
US20050031713A1
(en)
*
|
2003-08-06 |
2005-02-10 |
Elliot Ehrich |
Methods for administering active agents to CYP3A4 sensitive patients
|
JP2007533634A
(ja)
*
|
2003-09-30 |
2007-11-22 |
アキュスフィア, インコーポレイテッド |
注射、経口、または局所用の徐放性医薬製剤
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
WO2005070332A1
(en)
*
|
2004-01-12 |
2005-08-04 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US20050245461A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
US20050245541A1
(en)
*
|
2004-03-19 |
2005-11-03 |
Elliot Ehrich |
Methods for treating alcoholism
|
ES2375802T3
(es)
|
2004-04-15 |
2012-03-06 |
Alkermes Pharma Ireland Limited |
Dispositivo de liberación sostenida a base de pol�?mero.
|
US7919499B2
(en)
*
|
2004-04-22 |
2011-04-05 |
Alkermes, Inc. |
Naltrexone long acting formulations and methods of use
|
WO2005107714A2
(en)
*
|
2004-05-05 |
2005-11-17 |
Alkermes Controlled Therapeutics, Inc. |
Method of forming microparticles that include a bisphosphonate and a polymer
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
EP1758558B1
(en)
*
|
2004-05-12 |
2013-10-16 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
AU2005244840C1
(en)
|
2004-05-12 |
2012-05-10 |
Baxter Healthcare S.A. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
DE602005009954D1
(de)
*
|
2004-05-12 |
2008-11-06 |
Baxter Int |
Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
|
US20060253100A1
(en)
|
2004-10-22 |
2006-11-09 |
Medtronic, Inc. |
Systems and Methods to Treat Pain Locally
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
US20080213593A1
(en)
*
|
2005-01-21 |
2008-09-04 |
President And Fellows Of Harvard College |
Systems And Methods For Forming Fluidic Droplets Encapsulated In Particles Such As Colloidal Particles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
EP1885335A1
(en)
*
|
2005-04-27 |
2008-02-13 |
BAXTER INTERNATIONAL INC. (a Delaware corporation) |
Surface-modified microparticles and methods of forming and using the same
|
US20090317376A1
(en)
|
2005-06-06 |
2009-12-24 |
Georgetown University Medical School |
Compositions And Methods For Lipo Modeling
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
HUE045165T2
(hu)
|
2005-08-19 |
2019-12-30 |
Amylin Pharmaceuticals Llc |
Exendin diabetes kezelésére és testtömeg csökkentésére
|
US8852638B2
(en)
*
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070099947A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Alkermes, Inc. |
Methods and compositions for the treatment of brain reward system disorders by combination therapy
|
JP2009519972A
(ja)
*
|
2005-12-15 |
2009-05-21 |
アキュスフィア, インコーポレイテッド |
粒子ベースの経肺投与または経鼻投与用製薬の製造方法
|
EP1978933A2
(en)
*
|
2005-12-15 |
2008-10-15 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
US8182134B2
(en)
*
|
2005-12-16 |
2012-05-22 |
PRC De Soto International, Inc. |
Mixing system for thermoset compositions including static and rotary mixers
|
US7600911B2
(en)
*
|
2006-01-13 |
2009-10-13 |
Bechtold Gerald L |
Water-mixing device, sand trap and method of using same
|
US20070281031A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Guohan Yang |
Microparticles and methods for production thereof
|
EP2046435A4
(en)
*
|
2006-07-13 |
2012-06-27 |
Medtronic Inc |
METHOD AND FORMULATIONS FOR OPTIMAL LOCAL ADMINISTRATION OF CELL THERAPY BY MEANS OF MINIMALLY INVASIVE PROCEDURES
|
MX2009001226A
(es)
|
2006-08-04 |
2009-03-20 |
Baxter Int |
Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
MX2009003661A
(es)
*
|
2006-10-06 |
2009-04-22 |
Baxter Int |
Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
|
US20080098900A1
(en)
*
|
2006-11-01 |
2008-05-01 |
Babatunde Aremu |
Beverage manufacture using a static mixer
|
CA2680365A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
CN100548278C
(zh)
*
|
2007-05-17 |
2009-10-14 |
中国人民解放军军事医学科学院生物工程研究所 |
一种提高纳曲酮微球包封率的制备方法
|
EP2167039B1
(en)
|
2007-05-18 |
2016-09-28 |
Durect Corporation |
Improved depot formulations
|
CA2687979C
(en)
|
2007-05-25 |
2017-07-04 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of risperidone compounds
|
WO2008157540A1
(en)
*
|
2007-06-20 |
2008-12-24 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
UA96342C2
(en)
*
|
2007-06-25 |
2011-10-25 |
Оцука Фармасьютикал Ко., Лтд. |
Microspheres having core/shell structure
|
FR2918296B1
(fr)
*
|
2007-07-05 |
2009-09-18 |
Oreal |
Capsules de type noyau/ecorce et procede de preparation
|
NZ583632A
(en)
|
2007-11-16 |
2012-05-25 |
Univ Rockefeller |
Antibodies specific for the protofibril form of beta-amyloid protein
|
US20110081422A1
(en)
*
|
2007-11-19 |
2011-04-07 |
Capsulated Systems Inc. |
Prolonged release of local anesthetics using microparticles and surgery applications
|
WO2009085952A1
(en)
*
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
EP2259677A4
(en)
*
|
2008-02-29 |
2011-11-02 |
Alseres Pharmaceuticals Inc |
SYSTEMIC PURINARY ADMINISTRATION FOR MODULATING THE AXONAL GROWTH OF THE CENTRAL NERVOUS SYSTEM
|
US9216152B2
(en)
*
|
2008-06-27 |
2015-12-22 |
Tepha, Inc. |
Injectable delivery of microparticles and compositions therefore
|
US8323615B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US20100047292A1
(en)
*
|
2008-08-20 |
2010-02-25 |
Baxter International Inc. |
Methods of processing microparticles and compositions produced thereby
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8367427B2
(en)
*
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US20100087337A1
(en)
|
2008-09-10 |
2010-04-08 |
Bind Biosciences, Inc. |
High Throughput Fabrication of Nanoparticles
|
CA2736780C
(en)
*
|
2008-09-11 |
2017-01-17 |
Surmodics Pharmaceuticals, Inc. |
Solvent extraction microencapsulation with tunable extraction rates
|
KR101820024B1
(ko)
|
2008-10-17 |
2018-01-18 |
사노피-아벤티스 도이칠란트 게엠베하 |
인슐린과 glp-1 효능제의 병용물
|
WO2010057215A1
(en)
*
|
2008-11-17 |
2010-05-20 |
Wayne State University |
Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations
|
JP2012515790A
(ja)
*
|
2009-01-23 |
2012-07-12 |
サーモディクス ファーマシューティカルズ, インコーポレイテッド |
微粒子製造のための連続二重エマルジョン工程
|
US20100196436A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Gooberman Lance L |
Implants containing disulfiram and an anti-inflammatory agent
|
US8791093B2
(en)
*
|
2009-05-29 |
2014-07-29 |
Lance L. Gooberman |
Pharmaceutical delivery systems for treatment of substance abuse and other addictions
|
CN107638562B
(zh)
|
2009-09-28 |
2022-12-02 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
HUE037735T2
(hu)
|
2009-11-13 |
2018-09-28 |
Sanofi Aventis Deutschland |
DesPro36exendin-4(1-39)-Lys6-NH2-t és metionint tartalmazó gyógyszerkészítmény
|
ES2534191T3
(es)
|
2009-11-13 |
2015-04-20 |
Sanofi-Aventis Deutschland Gmbh |
Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
|
AU2011223807B2
(en)
*
|
2010-03-02 |
2016-05-12 |
Fervent Pharmaceuticals, Llc |
Methods and compositions for treating or preventing symptoms of hormonal variations
|
US8461102B2
(en)
|
2010-03-02 |
2013-06-11 |
George E. Royster, JR. |
Methods and compositions for treating and preventing symptoms of hormonal variations
|
US8207290B2
(en)
|
2010-03-26 |
2012-06-26 |
Cerulean Pharma Inc. |
Methods and systems for generating nanoparticles
|
UA111162C2
(uk)
|
2010-08-04 |
2016-04-11 |
Флекшен Терап'Ютікс, Інк. |
Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
|
US8778960B2
(en)
|
2010-08-23 |
2014-07-15 |
Alkermes Pharma Ireland Limited |
Methods for treating antipsychotic-induced weight gain
|
KR20130100290A
(ko)
|
2010-08-30 |
2013-09-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법
|
BR112013004756B1
(pt)
|
2010-08-30 |
2020-04-28 |
Sanofi Aventis Deutschland |
uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2
|
US8546521B2
(en)
|
2011-01-28 |
2013-10-01 |
Cerulean Pharma Inc. |
Method for fabricating nanoparticles
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
ES2642312T3
(es)
|
2011-08-04 |
2017-11-16 |
Flexion Therapeutics, Inc. |
Corticosteroides para el tratamiento del dolor de articulaciones
|
RU2650616C2
(ru)
|
2011-08-29 |
2018-04-16 |
Санофи-Авентис Дойчланд Гмбх |
Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
US10357496B2
(en)
|
2011-11-05 |
2019-07-23 |
South Alabama Medical Science Foundation |
Methods, formulations, and kits for rapidly repleting folate levels in women
|
US20150224176A1
(en)
|
2012-08-14 |
2015-08-13 |
Wockhardt Limited |
Pharmaceutical microparticulate compositions of polypeptides
|
EP2931300A1
(en)
|
2012-08-14 |
2015-10-21 |
Wockhardt Limited |
Pharmaceutical microparticulate compositions of polypeptides
|
US20150328377A1
(en)
*
|
2012-12-31 |
2015-11-19 |
Bacterin International, Inc. |
Composition of d-alpha hydroxy acids and antimicrobials
|
TWI641381B
(zh)
|
2013-02-04 |
2018-11-21 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
US9737605B2
(en)
|
2013-03-11 |
2017-08-22 |
Durect Corporation |
Injectable controlled release composition comprising high viscosity liquid carrier
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
US9895424B2
(en)
|
2014-01-09 |
2018-02-20 |
Sanofi |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
|
US9839692B2
(en)
|
2014-01-09 |
2017-12-12 |
Sanofi |
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
|
SG11201604706TA
(en)
|
2014-01-09 |
2016-07-28 |
Sanofi Sa |
Stabilized pharmaceutical formulations of insulin aspart
|
WO2015150942A2
(en)
|
2014-03-29 |
2015-10-08 |
The WOCKHARDT LIMITED |
Improved process for preparing microparticles
|
US9439864B2
(en)
|
2014-07-07 |
2016-09-13 |
Antriabio, Inc. |
Solvent extraction from biodegradable microparticles
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
JP6970615B2
(ja)
|
2014-12-12 |
2021-11-24 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
インスリングラルギン/リキシセナチド固定比処方
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
WO2017043494A1
(ja)
*
|
2015-09-07 |
2017-03-16 |
ニプロ株式会社 |
リスペリドンを含有するマイクロカプセル、その製造方法および放出制御方法
|
JP2017071740A
(ja)
*
|
2015-10-09 |
2017-04-13 |
信越化学工業株式会社 |
球状ポリオルガノシルセスキオキサン粒子の製造方法
|
CA3013904C
(en)
|
2016-02-10 |
2023-12-12 |
Rutgers, The State University Of New Jersey |
Novel anti-lam and anti-pim6/lam monoclonal antibodies for diagnosis and treatment of mycobacterium tuberculosis infections
|
WO2017160818A1
(en)
|
2016-03-14 |
2017-09-21 |
Flexion Therapeutics, Inc. |
Triamcinolone acetonide formulations for joint pain in diabetics
|
BR112018073511A2
(pt)
|
2016-05-16 |
2019-03-26 |
Intarcia Therapeutics, Inc. |
polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
|
WO2017199123A1
(en)
|
2016-05-17 |
2017-11-23 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Device and methods for shell phase removal of core-shell capsules
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
WO2018044970A1
(en)
|
2016-08-31 |
2018-03-08 |
University Of Rochester |
Human monoclonal antibodies to human endogenous retrovirus k envelope (herv-k) and uses thereof
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
KR102142026B1
(ko)
*
|
2017-05-31 |
2020-08-06 |
주식회사 대웅제약 |
방출제어가 용이한 서방성 약물 미립자의 제조방법
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
KR102259589B1
(ko)
*
|
2020-11-30 |
2021-06-02 |
(주)인벤티지랩 |
미소구체 제조 시스템 및 미소구체 제조 방법
|